MONDAY, Feb. 12, 2024 (Healthday News) -- Defense Secretary Lloyd Austin III, who spent time in intensive care last month for complications related to prostate cancer surgery performed in December, has returned to the hospital with bladder issues, the Pentagon announced Sunday.

"Tonight, after a series of tests and evaluations, the Secretary was admitted into the critical care unit at Wal...

Defense Secretary Lloyd Austin will not need any more treatment for his prostate cancer and his prognosis is "excellent," his doctors say.

The news came after a follow-up appointment Austin had at Walter Reed National Military Center on Friday.

"Beyond planned physical therapy and regular post-prostatectomy follow-up appointments, he has no planned further treatment for his cancer,"...

Following two weeks of hospital care for complications from prostate cancer surgery, U.S. Defense Secretary Lloyd Austin has been released from Walter Reed National Military Medical Center, the Pentagon announced Monday.

"Secretary Austin progressed well throughout his stay and his streng...

When most men think about their prostate, it's to worry about whether they have prostate cancer or not. But another condition is far more common and plenty painful.

Prostatitis involves inflammation of the prostate gland and sometimes the areas around it. Not only is prostatitis highly treatable, but it is highly prevalent among men. According to the Prostate Cancer Foundation, it is the ...

You're due for a prostate exam, but you don't know what to expect.

So, what is this exam like?

Regular check-ups are essential for maintaining your health, and a prostate exam is crucial to preventive care for men. Not only is it a screening test for early signs of prostate cancer, but it also helps detect other potential health issues.

Here, experts walk you ...

Over the last decade, more and more Americans with early-stage prostate cancer have put off radiation and surgery, the standard treatment options, new research indicates.

Instead, many U.S. men with low- or intermediate-risk prostate cancer have embraced "active surveillance,"in which their disease is carefully monitored for any sign of progression that might eventually require inter...

An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment.

The drug's maker, Novartis Pharmaceuticals Corp., has said it can't keep up with demand for the medication, known as Pluvicto.

Doctors have had to reschedule some patients who were due to start their first doses of the treatment. Mean...

Men suffering from an enlarged prostate can receive long-term relief from a minimally invasive procedure that partially blocks blood flow to the gland, new research reports.

The procedure, called prostate artery embolization (PAE), dramatically improved urinary symptoms in patients without having any effect on erectile function, said senior researcher